190 related articles for article (PubMed ID: 30790396)
21. Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.
Yau TM; Pagani FD; Mancini DM; Chang HL; Lala A; Woo YJ; Acker MA; Selzman CH; Soltesz EG; Kern JA; Maltais S; Charbonneau E; Pan S; Marks ME; Moquete EG; O'Sullivan KL; Taddei-Peters WC; McGowan LK; Green C; Rose EA; Jeffries N; Parides MK; Weisel RD; Miller MA; Hung J; O'Gara PT; Moskowitz AJ; Gelijns AC; Bagiella E; Milano CA;
JAMA; 2019 Mar; 321(12):1176-1186. PubMed ID: 30912838
[TBL] [Abstract][Full Text] [Related]
22. Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).
Santoso T; Siu CW; Irawan C; Chan WS; Alwi I; Yiu KH; Aziz A; Kwong YL; Tse HF
J Cardiovasc Transl Res; 2014 Aug; 7(6):545-52. PubMed ID: 25079593
[TBL] [Abstract][Full Text] [Related]
23. Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial.
McMurray JJV; Ponikowski P; Bolli GB; Lukashevich V; Kozlovski P; Kothny W; Lewsey JD; Krum H;
JACC Heart Fail; 2018 Jan; 6(1):8-17. PubMed ID: 29032139
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
25. Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results.
Qayyum AA; Mathiasen AB; Helqvist S; Jørgensen E; Haack-Sørensen M; Ekblond A; Kastrup J
J Transl Med; 2019 Nov; 17(1):360. PubMed ID: 31711513
[TBL] [Abstract][Full Text] [Related]
26. The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
Raval AN; Cook TD; Duckers HJ; Johnston PV; Traverse JH; Abraham WT; Altman PA; Pepine CJ
Am Heart J; 2018 Jul; 201():141-148. PubMed ID: 29803986
[TBL] [Abstract][Full Text] [Related]
27. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
[TBL] [Abstract][Full Text] [Related]
28. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
[TBL] [Abstract][Full Text] [Related]
29. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
[TBL] [Abstract][Full Text] [Related]
30. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
Florea V; Rieger AC; DiFede DL; El-Khorazaty J; Natsumeda M; Banerjee MN; Tompkins BA; Khan A; Schulman IH; Landin AM; Mushtaq M; Golpanian S; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Valasaki K; Pujol MV; Ghersin E; Miki R; Delgado C; Abuzeid F; Vidro-Casiano M; Saltzman RG; DaFonseca D; Caceres LV; Ramdas KN; Mendizabal A; Heldman AW; Mitrani RD; Hare JM
Circ Res; 2017 Nov; 121(11):1279-1290. PubMed ID: 28923793
[TBL] [Abstract][Full Text] [Related]
31. Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF).
Udelson JE; Lewis GD; Shah SJ; Zile MR; Redfield MM; Burnett J; Mittleman RS; Profy AT; Seferovic JP; Reasner D; Konstam MA
Am Heart J; 2020 Apr; 222():183-190. PubMed ID: 32105984
[TBL] [Abstract][Full Text] [Related]
32. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
Borow KM; Yaroshinsky A; Greenberg B; Perin EC
Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
[TBL] [Abstract][Full Text] [Related]
33. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
Martino H; Brofman P; Greco O; Bueno R; Bodanese L; Clausell N; Maldonado JA; Mill J; Braile D; Moraes J; Silva S; Bozza A; Santos B; Campos de Carvalho A;
Eur Heart J; 2015 Nov; 36(42):2898-904. PubMed ID: 26392433
[TBL] [Abstract][Full Text] [Related]
34. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
[TBL] [Abstract][Full Text] [Related]
35. REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.
Patel AN; Mittal S; Turan G; Winters AA; Henry TD; Ince H; Trehan N
Stem Cells Transl Med; 2015 Sep; 4(9):1021-7. PubMed ID: 26217065
[TBL] [Abstract][Full Text] [Related]
36. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.
Boriani G; Kranig W; Donal E; Calo L; Casella M; Delarche N; Lozano IF; Ansalone G; Biffi M; Boulogne E; Leclercq C;
Am Heart J; 2010 Jun; 159(6):1052-1058.e1. PubMed ID: 20569719
[TBL] [Abstract][Full Text] [Related]
37. Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy.
Carmona MD; Cañadillas S; Romero M; Blanco A; Nogueras S; Herrera C
Cytotherapy; 2017 Aug; 19(8):947-961. PubMed ID: 28673775
[TBL] [Abstract][Full Text] [Related]
38. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.
Zemljic G; Poglajen G; Sever M; Cukjati M; Frljak S; Androcec V; Cernelc P; Haddad F; Vrtovec B
J Card Fail; 2017 Feb; 23(2):153-160. PubMed ID: 27523610
[TBL] [Abstract][Full Text] [Related]
39. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Jorsal A; Kistorp C; Holmager P; Tougaard RS; Nielsen R; Hänselmann A; Nilsson B; Møller JE; Hjort J; Rasmussen J; Boesgaard TW; Schou M; Videbaek L; Gustafsson I; Flyvbjerg A; Wiggers H; Tarnow L
Eur J Heart Fail; 2017 Jan; 19(1):69-77. PubMed ID: 27790809
[TBL] [Abstract][Full Text] [Related]
40. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.
Penn MS; Mendelsohn FO; Schaer GL; Sherman W; Farr M; Pastore J; Rouy D; Clemens R; Aras R; Losordo DW
Circ Res; 2013 Mar; 112(5):816-25. PubMed ID: 23429605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
